G. Riethmüller
About
In The Last Decade
G. Riethmüller
16 papers receiving 278 citations
Peers
Comparison fields: 5 of 53
- Immunology 153
- Radiology, Nuclear Medicine and Imaging 108
- Rheumatology 74
- Molecular Biology 46
- Neurology 44
Countries citing papers authored by G. Riethmüller
This map shows the geographic impact of G. Riethmüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Riethmüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Riethmüller more than expected).
Fields of papers citing papers by G. Riethmüller
This network shows the impact of papers produced by G. Riethmüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Riethmüller. The network helps show where G. Riethmüller may publish in the future.
Co-authorship network of co-authors of G. Riethmüller
This figure shows the co-authorship network connecting the top 25 collaborators of G. Riethmüller. A scholar is included among the top collaborators of G. Riethmüller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Riethmüller. G. Riethmüller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | The hematopoietic system specific minor Histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells; relevance for immunotherapy of solid tumors. | 2 |
| 3 | 4 | |
| 4 | 13 | |
| 5 | 35 | |
| 6 | 2 | |
| 7 | ICAM-1 expression on alveolar macrophages and in serum of sarcoidosis patients. | 4 |
| 8 | 44 | |
| 9 | 16 | |
| 10 | Anti-CD4 therapy in rheumatoid arthritis. | 1 |
| 11 | 6 | |
| 12 | 23 | |
| 13 | 110 | |
| 14 | 9 | |
| 15 | [Monoclonal antibodies--new probes for diagnosis and therapy. Their use as an example of the micrometastasizing of solid tumors]. | 1 |
| 16 | In vivo and in vitro labelling of epithelial tumor cells with anti 17-1A monoclonal antibodies in bone marrow of cancer patients. | 10 |
| 17 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.